These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 8239836)

  • 1. Our experience with using the Pall LG6 leukocyte depleting filter during cardiopulmonary bypass.
    al-Ebrahim K; Shafei H
    Ann Thorac Surg; 1993 Nov; 56(5):1216-7. PubMed ID: 8239836
    [No Abstract]   [Full Text] [Related]  

  • 2. The effects of pulsatile flow on the leukocyte depleting qualities of the Pall LG6 leukocyte depleting arterial line filter: a laboratory investigation.
    Gourlay T; Fleming J; Taylor KM
    Perfusion; 1992 Jul; 7(3):227-32. PubMed ID: 10147703
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Laboratory evaluation of the Pall LG6 leukocyte depleting arterial line filter.
    Gourlay T; Fleming J; Taylor KM
    Perfusion; 1992 Apr; 7(2):131-40. PubMed ID: 10171549
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Biocompatibility of leukocyte removal filters during leukocyte filtration of cardiopulmonary bypass perfusate.
    Gu YJ; Obster R; Haan J; Gallandat Huet RC; Eijgelaar A; van Oeveren W
    Artif Organs; 1993 Jul; 17(7):660-5. PubMed ID: 8338443
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The influence of leukocyte filtration during cardiopulmonary bypass on postoperative lung function. A clinical study.
    Mihaljevic T; Tönz M; von Segesser LK; Pasic M; Grob P; Fehr J; Seifert B; Turina M
    J Thorac Cardiovasc Surg; 1995 Jun; 109(6):1138-45. PubMed ID: 7776678
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Leukocyte depleting filter attenuates myocardial injury during elective coronary artery bypass surgery.
    Koskenkari J; Rimpiläinen J; Biancari F; Surcel HM; Kaukoranta P; Kiviluoma K; Ala-Kokko T; Juvonen T
    Scand Cardiovasc J; 2005 Dec; 39(6):358-68. PubMed ID: 16352489
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pall leukocyte depleting filter during cardiopulmonary bypass.
    Allen SM; Pagano D; Bonser RS
    Ann Thorac Surg; 1994 Nov; 58(5):1560-1. PubMed ID: 7979703
    [No Abstract]   [Full Text] [Related]  

  • 8. Activation of neutrophils and monocytes by a leukocyte-depleting filter used throughout cardiopulmonary bypass.
    Ilmakunnas M; Pesonen EJ; Ahonen J; Rämö J; Siitonen S; Repo H
    J Thorac Cardiovasc Surg; 2005 Apr; 129(4):851-9. PubMed ID: 15821654
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Use of leukocyte-depleting filters during cardiac surgery with cardiopulmonary bypass: a review.
    Boodram S; Evans E
    J Extra Corpor Technol; 2008 Mar; 40(1):27-42. PubMed ID: 18389663
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [High pressure occlusion of leukocyte depletion arterial line filter in patients with cardio-pulmonary bypass surgery].
    Ogiwara M; Kyo S; Ohuchi H; Ueda K; Kenmoku K; Tanabe H; Asano H; Yokote Y
    Kyobu Geka; 2001 Aug; 54(9):759-63. PubMed ID: 11517545
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Use of polyester filters for the preparation of leukocyte-poor platelet concentrates.
    Snyder EL; DePalma L; Napychank P
    Vox Sang; 1988; 54(1):21-3. PubMed ID: 3348018
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Safety and efficacy of heparin-bonded surfaces in cardiopulmonary bypass.
    von Segesser LK
    J Thorac Cardiovasc Surg; 2001 Feb; 121(2):200-1. PubMed ID: 11174722
    [No Abstract]   [Full Text] [Related]  

  • 13. Laboratory studies of the effect of Pall extracorporeal leucocyte filters LG6 and AV6 on patients undergoing coronary bypass grafts.
    Thurlow PJ; Doolan L; Sharp R; Sullivan M; Smith B; Andersen LW
    Perfusion; 1996 Jan; 11(1):29-37. PubMed ID: 8904324
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The use of microfiltration in cardiopulmonary bypass.
    Joffe D; Silvay G
    J Cardiothorac Vasc Anesth; 1994 Dec; 8(6):685-92. PubMed ID: 7881002
    [No Abstract]   [Full Text] [Related]  

  • 15. Evaluation of leukocyte-reducing arterial line filter (LG6) for postoperative lung function, using cardiopulmonary bypass.
    Ohto T; Yamamoto F; Nakajima N
    Jpn J Thorac Cardiovasc Surg; 2000 May; 48(5):295-300. PubMed ID: 10860282
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prevention of the hypoxic reoxygenation injury with the use of a leukocyte-depleting filter.
    Bolling KS; Halldorsson A; Allen BS; Rahman S; Wang T; Kronon M; Feinberg H
    J Thorac Cardiovasc Surg; 1997 Jun; 113(6):1081-9; discussion 1089-90. PubMed ID: 9202689
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An in vitro comparison of the ability of three commonly used pediatric cardiopulmonary bypass circuits to filter gaseous microemboli.
    Melchior RW; Rosenthal T; Glatz AC
    Perfusion; 2010 Jul; 25(4):255-63; discussion 265-6. PubMed ID: 20566585
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Filtration of activated granulocytes during cardiopulmonary bypass surgery: a morphologic and immunologic study to characterize the trapped leukocytes.
    Smit JJ; de Vries AJ; Gu YJ; van Oeveren W
    J Lab Clin Med; 2000 Mar; 135(3):238-46. PubMed ID: 10711862
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Leukocyte depletion ameliorates free radical-mediated lung injury after cardiopulmonary bypass.
    Bando K; Pillai R; Cameron DE; Brawn JD; Winkelstein JA; Hutchins GM; Reitz BA; Baumgartner WA
    J Thorac Cardiovasc Surg; 1990 May; 99(5):873-7. PubMed ID: 2329826
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Leukocyte filtration improves brain protection after a prolonged period of hypothermic circulatory arrest: A study in a chronic porcine model.
    Rimpiläinen J; Pokela M; Kiviluoma K; Anttila V; Vainionpää V; Hirvonen J; Ohtonen P; Mennander A; Remes E; Juvonen T
    J Thorac Cardiovasc Surg; 2000 Dec; 120(6):1131-41. PubMed ID: 11088037
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.